Low VLDL causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 150: | Line 150: | ||
*[[Cystic fibrosis]] | *[[Cystic fibrosis]] | ||
*[[PCSK9#PCSK9 Deficiency|Deficiency of proprotein convertase subtilisin-like/kexin type 9]] | *[[PCSK9#PCSK9 Deficiency|Deficiency of proprotein convertase subtilisin-like/kexin type 9]] | ||
*[[Docosahexaenoic acid]]<ref name="pmid24136824">{{cite journal| author=Maitin V, Andreo U, Guo L, Fisher EA| title=Docosahexaenoic Acid Impairs the Maturation of Very Low Density Lipoproteins in Rat Hepatic Cells. | journal=J Lipid Res | year= 2013 | volume= | issue= | pages= | pmid=24136824 | doi=10.1194/jlr.M043026 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24136824 }} </ref> | |||
{{col-break|width=33%}} | |||
*[[Doxazosin]] | *[[Doxazosin]] | ||
*[[Exercise]]<ref name="pmid24075739">{{cite journal| author=Søndergaard E, Poulsen MK, Jensen MD, Nielsen S| title=Acute changes in lipoprotein subclasses during exercise. | journal=Metabolism | year= 2013 | volume= | issue= | pages= | pmid=24075739 | doi=10.1016/j.metabol.2013.08.011 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24075739 }} </ref> | *[[Exercise]]<ref name="pmid24075739">{{cite journal| author=Søndergaard E, Poulsen MK, Jensen MD, Nielsen S| title=Acute changes in lipoprotein subclasses during exercise. | journal=Metabolism | year= 2013 | volume= | issue= | pages= | pmid=24075739 | doi=10.1016/j.metabol.2013.08.011 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24075739 }} </ref> | ||
| Line 168: | Line 168: | ||
*[[Lipoprotein lipase deficiency]] | *[[Lipoprotein lipase deficiency]] | ||
*[[Liver failure]] | *[[Liver failure]] | ||
*[[Malignancy]] | |||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
*[[Malnutrition]] | *[[Malnutrition]] | ||
*[[Ménétrier's disease]] | *[[Ménétrier's disease]] | ||
Revision as of 20:16, 8 November 2013
|
Very Low Density Lipoprotein Microchapters |
|
Clinical Correlation |
|---|
|
Treatment |
|
Case Studies |
|
Low VLDL causes On the Web |
|
American Roentgen Ray Society Images of Low VLDL causes |
|
Directions to Hospitals Treating Very low density lipoprotein |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]
Overview
Inherited disorders of lipoprotein metabolism like abetalipoproteinemia and lipid lowering medications and diet are usually associated with low VLDL levels.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ Scanu, AM.; Aggerbeck, LP.; Kruski, AW.; Lim, CT.; Kayden, HJ. (1974). "A study of the abnormal lipoproteins in abetalipoproteinemia". J Clin Invest. 53 (2): 440–53. doi:10.1172/JCI107578. PMID 11344558. Unknown parameter
|month=ignored (help) - ↑ Welty, FK.; Mittleman, MA.; Wilson, PW.; Sutherland, PA.; Matheney, TH.; Lipinska, I.; Muller, JE.; Levy, D.; Tofler, GH. (1997). "Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population". Circulation. 95 (4): 825–30. PMID 9054738. Unknown parameter
|month=ignored (help) - ↑ Kim HJ, Moon JH, Kim HM, Yun MR, Jeon BH, Lee B; et al. (2013). "The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression". Metabolism. doi:10.1016/j.metabol.2013.09.006. PMID 24139096.
- ↑ Xiong W, Gu L, Wang C, Sun H, Liu X (2013). "Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice". J Ethnopharmacol. doi:10.1016/j.jep.2013.09.027. PMID 24095831.
- ↑ Maitin V, Andreo U, Guo L, Fisher EA (2013). "Docosahexaenoic Acid Impairs the Maturation of Very Low Density Lipoproteins in Rat Hepatic Cells". J Lipid Res. doi:10.1194/jlr.M043026. PMID 24136824.
- ↑ Søndergaard E, Poulsen MK, Jensen MD, Nielsen S (2013). "Acute changes in lipoprotein subclasses during exercise". Metabolism. doi:10.1016/j.metabol.2013.08.011. PMID 24075739.
- ↑ Zhang Y, Zhang L, Geng Y, Geng Y (2013). "Hawthorn Fruit Attenuates Atherosclerosis by Improving the Hypolipidemic and Antioxidant Activities in Apolipoprotein E-Deficient Mice". J Atheroscler Thromb. PMID 24126122.
- ↑ Rojas A, Del Campo JA, Maraver M, Aparcero R, García-Valdecasas M, Diago M; et al. (2013). "Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro". J Viral Hepat. doi:10.1111/jvh.12209. PMID 24188401.
- ↑ Wei Q, Wang H, Tian Y, Xu F, Chen X, Wang K (2013). "Reduced serum levels of triglyceride, very low density lipoprotein cholesterol and apolipoprotein B in Parkinson's disease patients". PLoS One. 8 (9): e75743. doi:10.1371/journal.pone.0075743. PMC 3784418. PMID 24086623.
- ↑ Liang YJ, Wang HP, Long DX, Li W, Wu YJ (2013). "A metabonomic investigation of the effects of 60days exposure of rats to two types of pyrethroid insecticides". Chem Biol Interact. 206 (2): 302–308. doi:10.1016/j.cbi.2013.10.002. PMID 24121187.
- ↑ Dash S, Xiao C, Morgantini C, Szeto L, Lewis GF (2013). "High-Dose Resveratrol Treatment for 2 Weeks Inhibits Intestinal and Hepatic Lipoprotein Production in Overweight/Obese Men". Arterioscler Thromb Vasc Biol. doi:10.1161/ATVBAHA.113.302342. PMID 24072699.